Glenmark Pharma shares up 2% after FDA grants fast track status to cancer drug
Glenmark Pharma's innovation arm, IGI, received FDA fast track designation for its myeloma therapy ISB 2001, targeting heavily pre-treated RRMM patients. The tri-specific antibody showed high response rates and a favorable safety profile in early trials. Complete results will be presented at (...)
Site référencé: The Economic Times
The Economic Times
China mulls opening communication lines with US on trade
2/05/2025
Funding woes force UN to weigh massive overhaul
2/05/2025
South Korea lurches from one political crisis to another
2/05/2025
India-Pak tensions : Pakistan says it has right to seek UNSC meeting
2/05/2025
US ends duty-free shipping loophole for low-cost goods from China
2/05/2025
RBI panel suggests longer call money hours, extended repo timings
2/05/2025
